Fig. 2: Availability of all categories of drugs.
From: The availability of drugs for stable COPD treatment in China: a cross-sectional survey
SABA Short-acting β2 agonist, LABA Long-acting β2 agonist, SAMA Short-acting antimuscarinics, LAMA long-acting antimuscarinics, ICS Inhaled corticosteroids.
